These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8947299)

  • 21. A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication.
    Herzig E; Voronin N; Kucherenko N; Hizi A
    J Virol; 2015 Aug; 89(16):8119-29. PubMed ID: 25995261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of HIV-1 reverse transcriptase inhibitors using a scintillation proximity assay.
    Van Schoubroeck B; Van Loock M; Ivens T; Dehertogh P; Jochmans D; Dams G
    Methods Mol Biol; 2013; 1030():19-24. PubMed ID: 23821257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 reverse transcription.
    Cimarelli A; Darlix JL
    Methods Mol Biol; 2014; 1087():55-70. PubMed ID: 24158814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
    Bakhanashvili M
    Oncogene; 2001 Nov; 20(52):7635-44. PubMed ID: 11753641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
    Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
    Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridine N-oxide derivatives inhibit viral transactivation by interfering with NF-kappaB binding.
    Stevens M; Pannecouque C; De Clercq E; Balzarini J
    Biochem Pharmacol; 2006 Apr; 71(8):1122-35. PubMed ID: 16438940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.
    Arion D; Kaushik N; McCormick S; Borkow G; Parniak MA
    Biochemistry; 1998 Nov; 37(45):15908-17. PubMed ID: 9843396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
    Oz Gleenberg I; Herschhorn A; Goldgur Y; Hizi A
    Arch Biochem Biophys; 2007 Feb; 458(2):202-12. PubMed ID: 17257575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription.
    Hooker CW; Lott WB; Harrich D
    J Virol; 2001 Apr; 75(7):3095-104. PubMed ID: 11238836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
    Julias JG; Ferris AL; Boyer PL; Hughes SH
    J Virol; 2001 Jul; 75(14):6537-46. PubMed ID: 11413321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
    Menéndez-Arias L
    Virus Res; 2008 Jun; 134(1-2):124-46. PubMed ID: 18272247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of reverse transcriptase activity increases stability of the HIV-1 core.
    Yang Y; Fricke T; Diaz-Griffero F
    J Virol; 2013 Jan; 87(1):683-7. PubMed ID: 23077298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
    Boyer PL; Julias JG; Ambrose Z; Siddiqui MA; Marquez VE; Hughes SH
    J Mol Biol; 2007 Aug; 371(4):873-82. PubMed ID: 17597154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of murine AIDS by pro-glutathione (GSH) molecules.
    Fraternale A; Paoletti MF; Casabianca A; Orlandi C; Schiavano GF; Chiarantini L; Clayette P; Oiry J; Vogel JU; Cinatl J; Magnani M
    Antiviral Res; 2008 Feb; 77(2):120-7. PubMed ID: 18164447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir.
    Kulkarni R; Feng JY; Miller MD; White KL
    Antiviral Res; 2014 Jan; 101():131-5. PubMed ID: 24291780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modular assembly of purine-like bisphosphonates as inhibitors of HIV-1 reverse transcriptase.
    Lacbay CM; Mancuso J; Lin YS; Bennett N; Götte M; Tsantrizos YS
    J Med Chem; 2014 Sep; 57(17):7435-49. PubMed ID: 25144111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma.
    Vázquez-Rosales G; García Lerma JG; Yamamoto S; Switzer WM; Havlir D; Folks TM; Richman DD; Heneine W
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1191-200. PubMed ID: 10480632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.